Disclosure of Drug Company Payments to Doctors Print Share

 
           I'm working to shed light on financial relationships between drug companies and doctors.  I've conducted oversight, and I'm working for passage of legislation that would require public reporting by drug companies of the money they give to doctors for consulting, travel, speeches, meals and other activities.  The public interest is clear.  We all rely on the advice of doctors, and leading researchers influence the practice of medicine.  Taxpayers spend billions of dollars each year on prescription drugs and devices through Medicare and Medicaid.  The National Institutes of Health distributes $24 billion annually in federal research grants.  So the public has a right to know about financial relationships between doctors and drug companies. 
 
 
 
Related News Stories and Editorial Comments:
 
Dr. Stephen L. Ondra, Director of Spine Surgery, Northwestern University
 
 
 
- Grassley letter to Medtronic, 21 October 2010
 
 
 
Dr. Melissa DelBello, Associate Professor of Psychiatry, University of Cincinnati
 
 
 
 
 
 
 
Dr. Alan Schatzberg, Chairman of the Department of Psychiatry, Stanford University
 
 
 
 
 
 
 
Dr. Joseph Biederman, Professor of Psychiatry, Harvard University
 
Dr. Timothy E. Wilens, Associate Professor of Psychiatry, Harvard University
 
-Carey, Benedict and Harris, Gardiner, "Researchers Fail to Reveal Full Drug Pay" The New York Times, 8 June 2008.
 
 
 
 
 
-Armstrong, David and Mundy, Alicia, "J&J Emails Raise Issues of Risperdal Promotion" The Wall Street Journal, 25 Nov 2008.
 
 
 
 
-Janet Frankston Lorin and John Lauerman, "Harvard Medical School to Review Drug Research Ethics (Update1)" Bloomberg, 15 Jan 2009.
 
 
 
 
 
 
 
Dr. Charles Nemeroff, Chairman of Psychiatry, Emory University
 
 
-Gellene, Denise and Maugh II, Thomas H. "Emory University Psychiatrist Accused of Conflict of Interest" Los Angeles Times, 4 Oct 2008.
 
 
 
 
 
 
 
 
-Pereira, Joseph, "Emory Professor Steps Down" Wall Street Journal, 23, Dec 2008.
 
 
 
 
 
 
 
Dr. Karen Wagner, Robert L. Stubblefield Professor and Vice Chair in the Department of Psychiatry and Behavioral Sciences and Director of the Division of Child and Adolescent Psychiatry at the University of Texas Medical Branch in Galveston
 
Dr. Augustus John Rush, Vice Dean of Clinical Sciences, Duke-NUS Graduate Medical School Singapore
 
 
 
 
 
 
 
Dr. Frederick K. Goodwin, Host, "The Infinite Mind"
 
 
 
 
 
-Garfield, Bob "Money Talks" On the Media, 28 Nov 2008.
 
 
 
Thomas Zdeblick, Professor and Chairman, Department of Orthopedics & Rehabilitation, University of Wisconsin
 
-Armstrong, David and Burton, Thomas M. "Medtronic Paid Researcher More Than $20,000 -- Much More" Wall Street Journal, 16 Jan 2009.
 
-Fauber, John, "Medical device maker paid UW surgeon $19 million: School didn't share in payments" Milwaukee Journal-Sentinel, 16 Jan 2009.
 
-Finkelmeyer, Todd, "UW responds to senator's inquiry into medical conflict of interest policy" The Capital Times, 26 Jan 2009.
 
 
-Fauber, John and Rust, Susan, "New rules on conflicts proposed" Milwaukee Journal Sentinel, 26 Feb 2009.
 
 
 
Dr. David Polly, Professor and Chief of the Spine Service, University of Minnesota
 
-Snowbeck, Christopher, U surgeon's fees face new scrutiny from payer, 31 Jul 2009. 
 
 
 
 
-Armstrong, David and Burton, Thomas M., "Spine Surgeon Didn't Disclose Medtronic Pay in Testimony," Wall Street Journal, 29 Jul 2009.
 
 
 
Dr. Timothy Kuklo, Associate Professor - Orthopaedic Surgery and Neurological Surgery, Washington University School of Medicine
 
 
-Burton, Thomas M. and Armstrong, David, "U.S. News: Grassley Probes Kuklo Study" The Wall Street Journal, 19 May 2009. 
 
 
 
 
 
Dr. Jeffrey C. Wang, UCLA
 
 
 
 
General Stories:
 
-Guess, Andy, "Researchers' Financial Disclosures in the Spotlight" Inside Higher Ed, 12 June 2008.
 
 
-Guess, Andy, "Accepting More Federal Oversight" Inside Higher Ed, 9 July 2008.
 
-Carey, Benedict and Harris, Gardiner, "Psychiatric Group Faces Scrutiny Over Drug Industry Ties" The New York Times, 12 July 2008.
 
-Firestone, Chaz and Kelsh, Chaz "Senator targets professor's ties to big pharma" Brown Daily Herald, 23 Sept 2008.
 
 
-Han, Tiffany and Rizzo, Salvador, "A National Policy Issue, But Close to Home" Emory Wheel, 6 Nov 2008.
 
 
-Meier, Barry, "Ties Between Doctors and Stent Makers Queried" The New York Times, 16 Oct 2008.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Editorials and Op-Eds:
 
-"Hidden Drug Payments at Harvard" The New York Times, 10 June 2008.
 
-Relman, Arnold S., "Improper Rewards of Research" The Boston Globe, 12 July 2008.
 
-"Credibility Crisis in Pediatric Psychiatry" Nature Neuroscience, Sep 2008.
 
-"Accountable Academics" The Brown Daily Herald, 24 Nov 2008.
 
-"Drugs and Disclosure" The New York Times, 10 Oct 2008.
 
-Warner, Judith "Diagnosis: Greed" The New York Times: Domestic Disturbances, 9 Oct 2008.
 
-"More Than One Bad Apple" Nature, 15 Oct 2008.
 
-"Time to Disinfect Research Dollars" Atlanta Journal Constitution, 12 Oct 2008.
 
-"Guarding Emory's Ethics" Emory Wheel, 6 Nov 2008.
 
-Restuccia, Robert, "Let Public See Doctors' Ties to Drug Companies" Atlanta Journal Constitution, 3 Nov 2008.
 
-"Defusing a time bomb" Nature Biotechnology, Oct 2008.
 
-"Expert or Shill?" The New York Times, 30 Nov 2008.
 
-Angell, Marcia, "Drug Companies & Doctors: A Story of Corruption" The New York Review of Books, 15 Jan 2009.